Literature DB >> 16369286

Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.

Oluseye A Oyawoye1, Bina Chander, Jocelyn Hunter, Ahmed Abdel Gadir.   

Abstract

OBJECTIVE: This study was designed to assess the efficacy of early aspiration of small follicles (EASF) in preventing moderate and severe ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovaries who experienced excessive ovarian response during the early part of assisted reproductive treatment cycles (ART). STUDY
DESIGN: EASF was undertaken transvaginally during 15 in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles in 14 women with polycystic ovaries who produced more than 20 small follicles during the early part of the cycle. A minimum of 10 small follicles. OUTCOMES: None of the patients developed moderate or severe OHSS. There were 9 intrauterine pregnancies (60 %) and 1 ectopic pregnancy.
CONCLUSIONS: EASF 4 to 7 days after starting gonadotropin injections prevented moderate and severe OHSS in susceptible patients with polycystic ovaries and resulted in a high pregnancy rate. Larger studies are needed to verify these promising results.

Entities:  

Mesh:

Year:  2005        PMID: 16369286      PMCID: PMC1681679     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  23 in total

Review 1.  Ovarian hyperstimulation syndrome: an update review.

Authors:  A Golan; R Ron-el; A Herman; Y Soffer; Z Weinraub; E Caspi
Journal:  Obstet Gynecol Surv       Date:  1989-06       Impact factor: 2.347

2.  The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos.

Authors:  N N Amso; K K Ahuja; N Morris; R W Shaw
Journal:  Fertil Steril       Date:  1990-06       Impact factor: 7.329

3.  Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome.

Authors:  A Z Isik; K Vicdan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-08       Impact factor: 2.435

Review 4.  Can we eliminate severe ovarian hyperstimulation syndrome?

Authors:  Raoul Orvieto
Journal:  Hum Reprod       Date:  2004-11-26       Impact factor: 6.918

5.  Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles.

Authors:  J Blankstein; J Shalev; T Saadon; E E Kukia; J Rabinovici; C Pariente; B Lunenfeld; D M Serr; S Mashiach
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

6.  Effect of follicular aspiration on hormonal parameters in patients undergoing ovarian stimulation.

Authors:  Y Gonen; W A Powell; R F Casper
Journal:  Hum Reprod       Date:  1991-03       Impact factor: 6.918

7.  Are there predictive criteria of complicated ovarian hyperstimulation in IVF?

Authors:  A Delvigne; J Vandromme; P Barlow; B Lejeune; F Leroy
Journal:  Hum Reprod       Date:  1991-08       Impact factor: 6.918

Review 8.  A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 May-Jun       Impact factor: 15.610

9.  Unilateral follicular aspiration and in-vitro maturation before contralateral oocyte retrieval: a method to prevent ovarian hyperstimulation syndrome.

Authors:  Annika K Schröder; Beate Schöpper; Saafa Al-Hasani; Klaus Diedrich; Michael Ludwig
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-10-10       Impact factor: 2.435

10.  Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups.

Authors:  R H Asch; H P Li; J P Balmaceda; L N Weckstein; S C Stone
Journal:  Hum Reprod       Date:  1991-11       Impact factor: 6.918

View more
  1 in total

1.  Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.

Authors:  Nayla J Bushaqer; Nawal M Dayoub; Khalsa K AlHattali; Hisham A Ayyoub; Samaher S AlFaraj; Samar N Hassan
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.